Momordica charantia fruit
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Momordica charantia fruit
- DrugBank Accession Number
- DB14265
- Background
Momordica charantia fruit is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- African Cucumber
- African Cucumber Fruit
- Balsam Pear
- Balsam Pear Fruit
- Balsam-pear (Bitter Gourd), Pods, Raw
- Balsam-pear (Bitter Gourd),pods,raw
- Balsampear Fruit
- Bitter Gourd
- Bitter Gourd Fruit
- Bitter Melon
- Bitter Melon Fruit
- Cucumis Argyi Fruit
- Karavellaka Fruit
- Ku Gua
- Momordica Charantia Fruit Extract
- Momordica Charantia Fruit Powder
- Momordica Chinensis Fruit
- Momordica Elegans Fruit
- Momordica Fruit (Momordica Charantia)
- Momordica Indica Fruit
- Momordica Operculata Fruit
- Momordica Sinensis Fruit
- Sicyos Fauriei Fruit
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Dangsim K-7 Granule 13 g/100g Oral Korea Genetic Pharm Co., Ltd 2012-02-07 Not applicable US Diabetes Out Liquid 0.5 g/1mL Oral CHANGJAE BENKO BIO Co., Ltd. 2022-03-14 Not applicable US Victory 19 Virus Out Liquid 0.5 g/1mL Oral CHANGJAE BENKO BIO Co., Ltd. 2021-09-21 2022-03-14 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Dangsim K-7 Momordica charantia fruit (13 g/100g) Granule Oral Korea Genetic Pharm Co., Ltd 2012-02-07 Not applicable US Diabetes Out Momordica charantia fruit (0.5 g/1mL) Liquid Oral CHANGJAE BENKO BIO Co., Ltd. 2022-03-14 Not applicable US Victory 19 Virus Out Momordica charantia fruit (0.5 g/1mL) Liquid Oral CHANGJAE BENKO BIO Co., Ltd. 2021-09-21 2022-03-14 US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- UA63Y8U89U
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Completed Treatment Type 2 Diabetes Mellitus 1 2 Withdrawn Treatment Type 2 Diabetes Mellitus 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Granule Oral 13 g/100g Liquid Oral 0.5 g/1mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 16:53